Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Class II Proposed For Posterior Cervical Screws

This article was originally published in The Gray Sheet

Executive Summary

The systems, which are used to treat spinal fractures and degenerative disease – among other conditions – are unclassified pre-amendment devices that have reached market via 510(k). FDA is proposing that multiple warnings be added to the product labeling as part of the reclassification.

You may also be interested in...

Ortho Panel Endorses Class II Status For Posterior Cervical Screws

FDA sought panel input on the previously unclassified devices in response to a 2011 petition from the Orthopedic Surgical Manufacturers Association.

Big Win For EMA On Transparency

The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.

UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts